title: Clinical pathology testing recommendations for nonclinical toxicity and safety studies. AACC-DACC/ASVCP Joint Task Force.
abstract: Clinical pathology testing in nonclinical toxicity and safety studies is an important part of safety assessment. In recent years, clinical laboratory testing has rapidly expanded and improved. Some government regulatory agencies provide guidelines for clinical pathology testing in nonclinical toxicity and safety studies. To improve these testing guidelines and the resultant safety assessments, the American Association for Clinical Chemistry's Division of Animal Clinical Chemistry and the American Society for Veterinary Clinical Pathology formed a joint committee to provide expert recommendations for clinical pathology testing of laboratory species involved in subchronic and chronic nonclinical toxicity and safety studies. These recommendations include technical recommendations on blood collection techniques and hematology, serum chemistry, and urinalysis tests.
authors.affiliation: Procter & Gamble Co., Miami Valley Laboratories, Cincinnati, Ohio 45239.
authors.forename: K
authors.initials: K
authors.lastname: Weingand
authors.forename: J
authors.initials: J
authors.lastname: Bloom
authors.forename: M
authors.initials: M
authors.lastname: Carakostas
authors.forename: R
authors.initials: R
authors.lastname: Hall
authors.forename: M
authors.initials: M
authors.lastname: Helfrich
authors.forename: K
authors.initials: K
authors.lastname: Latimer
authors.forename: B
authors.initials: B
authors.lastname: Levine
authors.forename: D
authors.initials: D
authors.lastname: Neptun
authors.forename: A
authors.initials: A
authors.lastname: Rebar
authors.forename: K
authors.initials: K
authors.lastname: Stitzel
mesh_terms: D000818:Animals; D010338:Pathology, Clinical / Q000592:standards*